Direct medical costs of RSV-related bronchiolitis hospitalizations in a middle-income tropical country

Stockman, 2012, Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997–2006, Pediatric Infect Dis J, 31, 5, 10.1097/INF.0b013e31822e68e6 Calvo, 2010, Detection of new respiratory viruses in hospitalized infants with bronchiolitis: a three-year prospective study, Acta Paediatrica (Oslo, Norway: 1992), 99, 883, 10.1111/j.1651-2227.2010.01714.x Miller, 2013, Viral etiologies of infant bronchiolitis, croup and upper respiratory illness during 4 consecutive years, Pediatric Infect Dis J, 32, 950, 10.1097/INF.0b013e31829b7e43 Skjerven, 2016, Virus type and genomic load in acute bronchiolitis: severity and treatment response with inhaled adrenaline, J Infect Dis, 213, 915, 10.1093/infdis/jiv513 Scheltema, 2017, Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series, Lancet Global Health, 5, e984, 10.1016/S2214-109X(17)30344-3 Hall, 2013, Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age, Pediatrics, 132, e341, 10.1542/peds.2013-0303 Berman, 1991, Epidemiology of acute respiratory infections in children of developing countries, Rev Infect Dis, 13, S454, 10.1093/clinids/13.Supplement_6.S454 Hall, 2009, The burden of respiratory syncytial virus infection in young children, N Engl J Med, 360, 588, 10.1056/NEJMoa0804877 Deshpande, 2003, The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area, Arch Dis Child, 88, 1065, 10.1136/adc.88.12.1065 Mahadevia, 2012, Cost utility of palivizumab prophylaxis among pre-term infants in the United States: a national policy perspective, J Med Econ, 15, 987, 10.3111/13696998.2012.690013 Weiner, 2012, Cost-effectiveness analysis of palivizumab among pre-term infant populations covered by Medicaid in the United States, J Med Econ, 15, 997, 10.3111/13696998.2012.672942 Novavax. Corporate update. http://novavax.com/presentation.show [accessed 11.07.18]. Gamba-Sanchez, 2016, Epidemic activity of respiratory syncytial virus is related to temperature and rainfall in equatorial tropical countries, Epidemiol Infect, 144, 2057, 10.1017/S0950268816000273 2011 Heikkila, 2015, Hospitalisation costs for infant bronchiolitis are up to 20 times higher if intensive care is needed, Acta Paediatrica (Oslo, Norway: 1992), 104, 269, 10.1111/apa.12881 Buendia, 2018, Cost illness of RSV infection in Colombia, Am J Respir Crit Care Med, 197, A3686 Lara-Oliveros, 2016, Disease burden and medical cost-analysis of Acute Respiratory Infections in a low-income district of Bogota, Revista de Salud Publica (Bogota Colombia), 18, 568, 10.15446/rsap.v18n4.45485 McLaurin, 2016, Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants, J Perinatol, 36, 990, 10.1038/jp.2016.113 Katz, 2003, Costs of respiratory syncytial virus infection at a tertiary-care children's hospital, P and T, 28, 343 Creery, 2005, Costs associated with infant bronchiolitis in the Baffin region of Nunavut, Int J Circumpolar Health, 64, 38, 10.3402/ijch.v64i1.17952 Pelletier, 2006, Direct medical costs of bronchiolitis hospitalizations in the United States, Pediatrics, 118, 2418, 10.1542/peds.2006-1193 Stang, 2001, The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalizations, Arch Pediatrics Adolesc Med, 155, 95, 10.1001/archpedi.155.1.95 Himmelstein, 2014, A comparison of hospital administrative costs in eight nations: US costs exceed all others by far, Health Affairs (Project Hope), 33, 1586, 10.1377/hlthaff.2013.1327 Papanicolas, 2018, Health care spending in the United States and other high-income countries, JAMA, 319, 1024, 10.1001/jama.2018.1150 Dieleman, 2017, Factors associated with increases in US health care spending, 1996–2013, JAMA, 318, 1668, 10.1001/jama.2017.15927 Bont, 2000, Long-term consequences of respiratory syncytial virus (RSV) bronchiolitis, Paediatr Respir Rev, 1, 221 Amand, 2018, Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis, BMC Health Serv Res, 18, 294, 10.1186/s12913-018-3066-1 Palmer, 2010, Healthcare costs within a year of respiratory syncytial virus among Medicaid infants, Pediatr Pulmonol, 45, 772, 10.1002/ppul.21244 Igde, 2018, Palivizumab prophylaxis, respiratory syncytial virus and subsequent development of asthma, Minerva Pediatr, 70, 252, 10.23736/S0026-4946.16.04368-1 Kovesi, 2018, Palivizumab prophylaxis and recurrent wheezing, Am J Respir Crit Care Med, 197, 679, 10.1164/rccm.201708-1643LE